Once-weekly insulin icodec vs once-daily insulin degludec in adults with insulin-naive type 2 diabetes: the ONWARDS 3 randomized clinical trial
Lingvay I, Asong M, Desouza C, et al.
JAMA. Pub. online 24 Jun 2023.
Leggi
Breaking news
Daily oral GLP-1 receptor agonist orforglipron for adults with obesity
Wharton S, Blevins T, Connery L, et al.
N Engl J Med. Pub. online 23 Jun 2023.
Leggi
Comparative efficacy and safety of Gla‐300 versus IDegAsp in insulin‐naïve people with type 2 diabetes mellitus uncontrolled on oral anti‐diabetics
Ritzel R, Ghosh S, Emral R, et al.
Diabetes Obes Metab. Pub. online 13 Jun 2023.
Leggi
Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study)
Collier A, Curran C, Cameron L, et al.
Diabetes Obes Metab. Pub. online 13 Jun 2023.
Leggi
Physical activity and the development of islet autoimmunity and type 1 diabetes in 5- to 15-year-old children followed in the TEDDY study
Liu X, Johnson SB, Lynch KF, et al.
Diabetes Care. 2023;46(7):1409-1416.
Leggi
Risk of breakthrough SARS‐CoV‐2 infection and clinical outcomes among vaccinated patients with type 2 diabetes
Bea S, Choi A, Kim JH, et al.
Diabetes Obes Metab. Pub. online 13 Jun 2023.
Leggi
Potential value of identifying type 2 diabetes subgroups for guiding intensive treatment: a comparison of novel data-driven clustering with risk-driven subgroups
Li X, van Giessen A, Altunkaya J, et al.
Diabetes Care. 2023;46(7):1395-1403.
Leggi
The association between body weight indices, behavioural factors, and type 2 diabetes mellitus in Africa: a systematic review and meta-analysis of population-based epidemiological studies
Issaka A, Paradies Y, Cameron AJ, Stevenson C
NMCD. Pub. online 19 Jun 2023.
Leggi
Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease
Heinrich NS, Pedersen RP, Vestergaard MB, et al.
Diabetes Obes Metab. Pub. online 6 Jun 2023.
Leggi
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy
Hammer SS, Dorweiler TF, McFarland D, et al.
Diabetologia. Pub. online 14 Jun 2023.
Leggi